Recently, the ThinLinc team traveled to Copenhagen, Denmark, to visit customers. One of the customers visited was the Neurobiology Research Unit (NRU) at Copenhagen University Hospital Rigshospitalet. Jean, Pierre and Tobias talked to Claus Svarer about how ThinLinc is used and helps the researchers’ work.
In summary, NRU conducts innovative diagnostic, therapeutic and preventive neuropharmacological research. The organization also maintains a close relationship with hospital clinics, academia and industry, enabling immediate subsequent execution of prevention strategies, diagnostics and innovative drugs as well as non-pharmacological treatments of patients with brain disorders.
ThinLinc is proud to be able to talk face to face with our customers, and we are honored to share knowledge and learn even more with the NRU.